Application of oncogenetic trees mixtures as a biostatistical model of the clonal cytogenetic evolution of meningiomas

International Journal of Cancer

Volumn 121, Issue 7, 2007, Pages 1473-1480

  Ketter, Ralf ^a   Urbschat, Steffi ^a   Henn, Wolfram ^a   Feiden, Wolfgang ^a   Beerenwinkel, Niko ^b   Lengauer, Thomas ^b   Steudel, Wolf Ingo ^a   Zang, Klaus D ^a   Rahnenführer, Jörg ^b  

^a SAARLAND UNIVERSITY   (Germany)

^b MAX PLANCK INSTITUTE FOR INFORMATICS   (Germany)

Author keywords

Chromosomes; Genetic progression score; Meningioma; Oncogenetic trees

Indexed keywords

ADULT; ANAPLASTIC CARCINOMA; ARTICLE; BIOSTATISTICS; CELL CLONING; CHROMOSOME 22; CONTROLLED STUDY; CYTOGENETICS; DISEASE COURSE; FEMALE; GENE DELETION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; KARYOTYPE; MAJOR CLINICAL STUDY; MALE; MATHEMATICAL MODEL; MENINGIOMA; MONOSOMY; ONCOGENE; PRIORITY JOURNAL; SCORING SYSTEM;

ADULT; AGED; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 22; CLONE CELLS; CYTOGENETICS; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GENE DELETION; HUMANS; KARYOTYPING; MALE; MENINGEAL NEOPLASMS; MENINGIOMA; MIDDLE AGED; MODELS, GENETIC; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES; SEX FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 34548216812     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.22855     Document Type: Article

References (44)

1. Louis DN, Scheithauer BW, Budka H, von Deimling A, Kepes JJ. Meningiomas. In: Kleihues P, Cavenee WP, eds. WHO classification of tumours: tumours of the nervous system. Lyon: IARC Press, 2000;176-89.
2. İldan F, Tuna M, Göçer AI, Boyar B, Bagdatoglu H, Şen O, Haciyakupoǧlu S, Burgut R. Correlation of the relationships of brain-tumor interfaces, magnetic resonance imaging, and angiographic findings to predict cleavage of meningiomas. J Neurosurg 1999;91:384-90.
3. Mantle RE, Lach B, Delgado MR, Baeesa S, Belanger G. Predicting the probability of meningioma recurrence based on the quantity of peritumoral brain edema on computerized tomography scanning. J Neurosurg 1999;91:375-86.
4. Niedermayer I, Kolles H, Zang KD, Feiden W. Characterization of intermediate type (WHO "atypical") meningiomas. Clin Neuropathol 1996;15:330-6.
5. Jellinger K, Slowik. Histological subtypes and prognostic problems in meningioma. J Neurol 1975;208:279-98.
6. Jellinger K. Histopathological features predicting recurrence of meningiomas after (sub)total resection. Clin Neuropathol 1988;7:174.
7. McLean CA, Jolley D, Cukier E, Giles G, Gonzales MF. Atypical and malignant meningiomas: importance of micronecrosis as a prognostic indicator. Histopathology 1993;23:349-53.
8. Takeuchi H, Kubota T, Kabuto M, Kitai R, Nozaki J, Yamashita J. Prediction of recurrence in histologically benign meningiomas: proliferating cell nuclear antigen and Ki-67 immunohistochemical study. Surg Neurol 1997;48:501-6.
9. Zang KD, Singer H. Chromosomal constitution of meningiomas. Nature 1967;216:84-5.
10. Zankl H, Zang KD. Correlation between clinical and cytogenetical data in 180 human meningiomas. Cancer Genet Cytogenet 1980;1:351-6.
11. Perry A, Gutmann DH, Reifenberger G. Molecular pathogenesis of meningiomas. J Neurooncol 2004;70:183-302.
12. Bello MJ, de Campos JM, Kusak ME, Vaquero J, Sarasa JL, Pestana A, Rey JA. Allelic loss of lp is associated with tumor progression of meningiomas. Genes Chromosomes Cancer 1994;9:296-8.
13. Henn W, Cremerius U, Heide G, Lippitz B, Schroder JM, Gilsbach JM, Bull U, Zang KD. Monosomy lp is correlated with enhanced in vivo glucose metabolism in meningiomas. Cancer Genet Cytogenet 1995;79:144-8.
14. Kolles H, Niedermayer I, Schmitt Ch, Henn W, Feld R, Steudel WI, Zang KD, Feiden W. Triple approach for diagnosis and grading of meningiomas: histology, morphometry of Ki-67/Feulgen stainings, and cytogenetics. Acta Neurochir (Vienna) 1995;137:174-81.
15. Mueller P, Henn W, Niedermayer I, Ketter R, Feiden W, Steudel WI, Zang KD, Steilen-Gimbel . Deletion of chromosome 1p and loss of expression of alkaline phosphatase indicate progression of meningiomas. Clin Can Res 1999;5:3569-77.
16. Niedermayer I, Feiden W, Henn W, Steilen-Gimbel H, Steudel WI, Zang KD. Loss of alkaline phosphatase activity in meningiomas: a rapid histochemical technique indicating progression-associated deletion of a putative tumor suppressor gene on the distal part of the short arm of chromosome 1. J Neuropathol Exp Neurol 1997;56:879-86.
17. Simon M, von Deimling A, Larson JJ, Wellenreuther R, Kaskel P, Waha A, Warnick RE, Tew JM, Jr, Menon AG. Allelic loss on chromosomes 14, 10 and 1 in atypical and malignant meningiomas: a genetic model of meningioma progression. Cancer Res 1995;55:4696-701.
18. Ketter R, Henn W, Niedermayer I, Steilen-Gimbel H, König J, Zang KD, Steudel WI. Predictive value of progression-associated chromosomal aberrations for the prognosis of meningiomas: a retrospective study of 198 cases. J Neurosurg 2001;95:601-7.
19. Zang KD. Meningioma: a cytogenetic model of a complex benign human tumor, including data on 394 karyotyped cases. Cytogenet Cell Genet 2001;93:207-20.
20. Weber RG, Bostrom J, Wolters M, Baudis M, Collins P, Reifenberger G, Lichter P. Analysis of genomic alterations in benign, atypical, and anaplastic meningiomas: Toward a genetic model of meningioma progression. Proc Natl Acad Sci USA 1997;94:14719-24.
21. Steudel WI, Feld R, Henn W, Zang KD. Correlation between cytogenetic and clinical findings in 215 human meningiomas. Acta Neurochir[Suppl]1996;65:73-6.
22. Jiang F, Desper R, Papadimitriou CH, Schaffer AA, Kallioniemi OP, Richter J, Schraml P, Sauter G, Mihatsch MJ, Moch H. Construction of evolutionary tree models for renal cell carcinoma from comparative genomic hybridization data. Cancer Res 2000;60:6503-9.
23. Beerenwinkel N, Rahnenführer J, Daumer M, Hoffmann D, Kaiser R, Selbig J, Lengauer T. Learning multiple evolutionary pathways from cross-sectional data. J Comput Biol 2005a;12:584-98.
24. Desper R, Jiang F, Kallioniemi OP, Moch H, Papadimitriou CH, Schäffer AA. Inferring tree models for oncogenesis from comparative genome hybridization data. J Comput Biol 1999;6:37-51.
25. von Heydebreck A, Gunawan B, Fuzesi L. Maximum likelihood estimation of oncogenetic tree models. Biostatistics 2004;5:545-56.
26. Cox DR. Regression models and life tables (with Discussion), J R Stat Soc Ser B 1972;34:187-4.
27. Simpson D. The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry 1957;20:22-39.
28. Limon J, Dal-Cin P, Sandberg AA. Application of long-term collagenase disaggregation for the cytogenetic analysis of human solid tumors. Cancer Genet Cytogenet 1986;23:305-13.
29. Beerenwinkel N, Rahnenfuhrer J, Kaiser R, Hoffmann D, Selbig J, Lengauer T. Mtreemix: a software package for learning and use mixture models of mutagenetic trees. Bioinformatics 2005b;21:2106-7.
30. Rahnenfuhrer R, Beerenwinkel N, Schulz WA, Hartmann C, von Deimling A, Wullich B, Lengauer T. Estimating cancer survival and clinical outcome based on genetic tumor progession scores. Bioinformatics 2005;21:2438-46.
31. Chan RC, Thompson GB. Morbidity, mortality, and quality of life following surgery for intracranial meningiomas. A retrospective study in 257 cases. J Neurosurg 1984;60:52-60.
32. Zülch KJ. Histological classification of tumors of the central nervous system, in International Histological Classification of Tumours No. 21. Geneva: World Health Organization, 1979, pp 47-60.
33. Adegbite AB, Khan MI, Paine KWE, Tan LK. The recurrence of intracranial meningiomas after surgical treatment. J Neurosurg 1983;58:51-6.
34. Mirimanoff RO, Dosoretz DE, Linggood RM, Ojemann RG, Martuza RL. Meningioma, analysis of recurrence and progression following neurosurgical resection. J Neurosurg 1985;62:18-24.
35. Scheithauer BW. Tumors of the meninges: proposed modifications of the World Health Organisation classification. Acta Neuropathol 1990;80:343-54.
36. Cushing H. The cranial hyperostoses producted by meningeal endotheliomas. Arch Neurol Psychiat 1922;8:139-52.
37. McCarthy BJ, Davis FG, Freels S, Surawicz TS, Damek DM, Grutsch J, Meneck HR, Lawser JR. Factors associated with survival in patients with meningioma. J Neurosurg 1998;88:831-9.
38. Mahmood A, Caccamo DV, Tomecek FJ, Malik GM. Atypical and malignant meningiomas: a clinicopathological review. Neurosurgery 1993;33:955-63.
39. Perry A, Jenkins RB, Dahl RJ, Moertel CA, Scheithauer BW. Cytogenetic analysis of aggressive meningiomas. Cancer 1996;77:2567-73.
40. Maíllo A, Orfao A, Sayagués JM, Diaz P, Gomez-Moreta JA, Caballero M, Santamarta D, Santos-Briz A, Morales F, Tabernero MD. New classification scheme for the prognostic stratification of meningioma on the basis of chromosome 14 abnormalities, patient age, and tumor histopathology. J Clin Oncol 2003;21:3285-95.
41. Sayagués JM, Tabernero MD, Maíllo A, Espinosa A, Rasillo A, Díaz P, Ciudad J, López A, Merino M, Goncalves JM, Santos-Briz A, Morales F et al. Intratumoral patterns of clonal evolution in meningiomas as defined by multicolor interphase fluorescence in situ hybridization (FISH). J Mol Diagn 2004;6:316-25.
42. Menon GM, Rutter JL, von Sattel JP, Synder H, Murdoch C, Blumenfeld A, Martuza RL, von Deimling A, Gusella JF, Houseal TW. Frequent loss of chromosome 14 in atypical and malignant meningioma: identification of a putative "tumor progression" locus. Oncogene 1997;14:611-16.
43. Espinosa AB, Tabernero MD, Maillo A, Sayagues JM, Ciudad J, Merino M, Alguero MC, Lubombo AM, Sousa P, Santos-Briz A, Orfao A. The cytogenetic relationship between primari and recurrent meningiomas points to the need for new treatment strategies in cases at high risk of relapse. Clin Cancer Res 2006;12:772-80.
44. Zang KD. Cytological and cytogenetical studies on human meningioma. Cancer Genet Cytogenet 1982;6:249-74.